» Articles » PMID: 8065464

Effects of Human Recombinant Interleukins on Stimulation-evoked Noradrenaline Overflow from the Rat Perfused Spleen

Overview
Specialty Pharmacology
Date 1994 May 1
PMID 8065464
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Experiments were carried out in the isolated spleen of the rat to study in a lymphoid organ the influence of interleukins (ILs) on noradrenaline release. Spleens were perfused with Tyrode's solution and the overflow of endogenous noradrenaline was determined by HPLC with electrochemical detection. Perivascular electrical stimulation (4 or 10 Hz, 20-28 mA, 2 min) caused an increase in noradrenaline overflow and in perfusion pressure, both of which were markedly reduced by perfusion with Ca(2+)-free solution, abolished by tetrodotoxin, unaffected by hexamethonium, and subject to alpha 2-adrenoceptor- and muscarinic receptor-mediated modulation as shown by the effects of rauwolscine and methacholine. Human recombinant IL-1 beta and IL-2 and mouse recombinant IL-2 10 ng/ml failed to affect the evoked overflow of noradrenaline after an exposure time of 15 min. In contrast, human recombinant IL-1 beta and IL-2 0.1 ng/ml reduced the evoked overflow after exposure for 80 min; the inhibition tended to increase 30 min later despite washout. Murine recombinant IL-2 1.2 ng/ml caused no change after contact with the tissue for 80 min but there was an inhibition 30 min later after washout. Human recombinant IL-6 (0.1 ng/ml) caused no significant change. The inhibitory effect of low concentrations of IL-1 beta and IL-2 supports the idea that locally produced mediators of the immune system may affect neuronal function.

Citing Articles

Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms.

Korte S, Straub R Rheumatology (Oxford). 2019; 58(Suppl 5):v35-v50.

PMID: 31682277 PMC: 6827268. DOI: 10.1093/rheumatology/kez413.


Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis.

Byrne C, Khurana S, Kumar A, Tai T Front Endocrinol (Lausanne). 2018; 9:343.

PMID: 30013513 PMC: 6036303. DOI: 10.3389/fendo.2018.00343.


Autonomic nervous system and immune system interactions.

Kenney M, Ganta C Compr Physiol. 2014; 4(3):1177-200.

PMID: 24944034 PMC: 4374437. DOI: 10.1002/cphy.c130051.


Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection.

Miura T, Kudo T, Matsuki A, Sekikawa K, Tagawa Y, Iwakura Y Infect Immun. 2001; 69(12):7234-41.

PMID: 11705892 PMC: 98806. DOI: 10.1128/IAI.69.12.7234-7241.2001.


Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from mice isolated atria.

Foucart S, Abadie C Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(1):1-6.

PMID: 8832581 DOI: 10.1007/BF00168699.


References
1.
Bochner B, Charlesworth E, Lichtenstein L, Derse C, Gillis S, Dinarello C . Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol. 1990; 86(6 Pt 1):830-9. DOI: 10.1016/s0091-6749(05)80143-5. View

2.
Akiyoshi M, Shimizu Y, Saito M . Interleukin-1 increases norepinephrine turnover in the spleen and lung in rats. Biochem Biophys Res Commun. 1990; 173(3):1266-70. DOI: 10.1016/s0006-291x(05)80923-4. View

3.
Karasuyama H, Melchers F . Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol. 1988; 18(1):97-104. DOI: 10.1002/eji.1830180115. View

4.
Hertting G, Axelrod J, PATRICK R . Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br J Pharmacol Chemother. 1962; 18:161-6. PMC: 1482176. DOI: 10.1111/j.1476-5381.1962.tb01159.x. View

5.
Whitacre C . Immunology. A state of the art lecture. Ann N Y Acad Sci. 1990; 594:1-16. DOI: 10.1111/j.1749-6632.1990.tb40463.x. View